Frontlight ResearchEarly access
Trial site
Tennessee Cancer Specialists
- 9running trials
- 7closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Metastatic breast cancer3 trials
- Head and neck cancer2 trials
- Pancreatic cancer2 trials
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Myelodysplastic syndromes1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 310 trials
- Phase 26 trials
- Status
- Recruiting5 trials
- Active, not recruiting3 trials
- Terminated3 trials
- Completed2 trials
- Withdrawn2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Veru Inc.2 trials
- Amgen1 trial
- Corbus Pharmaceuticals Inc.1 trial
- Eikon Therapeutics1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Head and neck cancer2 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
- Prostate cancer1 recruiting
Closed trials
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Withdrawn
Terminated
Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer
Terminated
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026